Neuraxis, Inc. Form 8-K Summary
Business Context and Reporting Period
Neuraxis, Inc. (NRXS), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on June 4, 2025, regarding events occurring on May 29, 2025. The filing details the results of the Company's Annual Meeting of Stockholders held in Carmel, Indiana.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
The Annual Meeting achieved a quorum with 5,660,885 votes represented, approximately 59.22% of outstanding votes. As of the record date (March 31, 2025), there were 7,215,864 shares of Common Stock and 4,280,939 shares of Series B Preferred Stock outstanding.
- Director Elections: All six nominees were elected to one-year terms. Dr. Christopher R. Brown received the lowest support with 94.41% of votes cast for him, while the other five directors received between 98.46% and 99.82% support.
- Accounting Firm Ratification: The appointment of Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was approved with 5,655,664 votes for, 0 against, and 5,221 abstentions.
- Stock Issuance Proposal: A proposal to authorize the issuance of 20% or more of outstanding Common Stock upon the conversion of Series B Convertible Preferred Stock was approved. The vote was 4,127,496 for, 128,811 against, and 268,250 abstained. Notably, there were 1,136,328 broker non-votes on this matter.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly limited to reporting the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the impact of the approved Series B Preferred Stock conversion on future share dilution.
- Review the specific terms of the Series B Convertible Preferred Stock to understand the conversion mechanics.
- Confirm the tenure and background of the newly elected board members, particularly Dr. Christopher R. Brown who received a higher percentage of withheld votes.
- Check subsequent filings (e.g., 10-K or 10-Q) for the actual financial performance data absent from this report.